Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Equilibrative nucleoside transporter (ENT) | ||||||
Solute carrier family 29 member 4 (SLC29A4) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (138T) of SLC29A4 | |||||
Induced Change | Dopamine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Asperger syndrome [ICD-11: 6A02] | |||||
Details | It is reported that mutation (138T) of SLC29A4 leads to the decrease of dopamine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (D326E) of SLC29A4 | |||||
Induced Change | Dopamine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Asperger syndrome [ICD-11: 6A02] | |||||
Details | It is reported that mutation (D326E) of SLC29A4 leads to the decrease of dopamine levels compared with control group. | |||||
GPCR glutamate (GPCR-3) | ||||||
Glutamate receptor mGLU2 (mGluR2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of Grm2 | |||||
Induced Change | Dopamine concentration: decrease (FC = 0.75) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of mGlu2/3 leads to the decrease of dopamine levels compared with control group. | |||||
Glutamate receptor mGLU3 (mGluR3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockout of Grm3 | |||||
Induced Change | Dopamine concentration: decrease (FC = 0.75) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of mGlu2/3 leads to the decrease of dopamine levels compared with control group. | |||||
GPCR rhodopsin (GPCR-1) | ||||||
Dopamine D4 receptor (D4R) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Knockout of Drd4 | |||||
Induced Change | Dopamine concentration: decrease (FC = 0.28) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of DRD4 leads to the decrease of dopamine levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Dopamine concentration: decrease (Log2 FC=0.8) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the decrease of dopamine levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.